SCHEMBL3137983

SCHEMBL3137983

CCOC(=O)c1scc(C#N)c1I

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 1/20 0.45
MAPK9 P45984 1/20 0.45
MAPK10 P53779 1/20 0.45
KDM4E B2RXH2 7/20 0.42
ALDH1A1 P00352 6/20 0.42
HPGD P15428 2/20 0.42
RXFP1 Q9HBX9 2/20 0.42
HSD17B10 Q99714 2/20 0.42
MEN1 O00255 2/20 0.42
MAPT P10636 2/20 0.42
KMT2A Q03164 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
GAA P10253 1/20 0.40
FNTA P49354 2/20 0.39
FNTB P49356 2/20 0.39
APOBEC3G Q9HC16 1/20 0.39
GSK3B P49841 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
BRAF P15056 1/20 0.38
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5474697 0.84 ALDH1A1 (0.47) MAPK8MAPK9MAPK10KDM4EALDH1A1
SCHEMBL3125258 0.82 KDM4E (0.48) MAPK8MAPK9MAPK10KDM4EALDH1A1
SCHEMBL3139168 0.80 ALDH1A1 (0.44) MAPK8MAPK9MAPK10KDM4EALDH1A1
SCHEMBL18430412 0.78 MAPK8 (0.45) MAPK8MAPK9MAPK10KDM4EALDH1A1
SCHEMBL5732187 0.74 HTT (0.49) MAPK8MAPK9MAPK10KDM4EALDH1A1
SCHEMBL5732188 0.72 MAPK8 (0.41) MAPK8MAPK9MAPK10KDM4EALDH1A1
SCHEMBL3131470 0.72 L3MBTL1 (0.52) KDM4EALDH1A1HPGDRXFP1HSD17B10
SCHEMBL623720 0.72 L3MBTL1 (0.52) KDM4EALDH1A1HPGDRXFP1MEN1
SCHEMBL3128599 0.72 GRIA2 (0.47) MAPK8MAPK9MAPK10KDM4EALDH1A1
SCHEMBL18430407 0.71 MAPK8 (0.47) MAPK8MAPK9MAPK10KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7642361-B2 Thiophene and furan compounds ELI LILLY AND COMPANY (US) 2010-01-05 US disclosed
US-7642361-B2 Thiophene and furan compounds ELI LILLY AND COMPANY (US) 2010-01-05 US disclosed
US-20070105852-A1 Thiophene and furan compounds ELI LILLY AND COMPANY 2007-05-10 US disclosed
US-20070105852-A1 Thiophene and furan compounds ELI LILLY AND COMPANY 2007-05-10 US disclosed
EP-1706395-A1 THIOPHENE AND FURAN COMPOUNDS ELI LILLY AND COMPANY (US) 2006-10-04 EP disclosed
WO-2005070916-A1 THIOPHENE AND FURAN COMPOUNDS ELI LILLY AND COMPANY (US) 2005-08-04 WO disclosed
WO-2005070916-A1 THIOPHENE AND FURAN COMPOUNDS ELI LILLY AND COMPANY (US) 2005-08-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105852-A1 Thiophene and furan compounds PSEN2, PSEN1, TPMT MAPK8 4201/4885MAPK9 4532/4885MAPK10 3448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.